65 related articles for article (PubMed ID: 6732364)
1. Unique [3H]tryptamine binding sites in rat brain: distribution and pharmacology.
Wood PL; Pilapil C; LaFaille F; Nair NP; Glennon RA
Arch Int Pharmacodyn Ther; 1984 Apr; 268(2):194-201. PubMed ID: 6732364
[TBL] [Abstract][Full Text] [Related]
2. The [3H]tryptamine receptor in human brain: kinetics, distribution, and pharmacologic profile.
Mousseau DD; Butterworth RF
J Neurochem; 1994 Sep; 63(3):1052-9. PubMed ID: 8051546
[TBL] [Abstract][Full Text] [Related]
3. Biochemical characterization of [3H]tryptamine binding sites from rat brain.
Brüning G; Rommelspacher H
Biochem Int; 1989 Jan; 18(1):227-33. PubMed ID: 2541722
[TBL] [Abstract][Full Text] [Related]
4. Serotoninergic receptors in brain tissue: properties and identification of various 3H-ligand binding sites in vitro.
Leysen JE
J Physiol (Paris); 1981; 77(2-3):351-62. PubMed ID: 7288650
[TBL] [Abstract][Full Text] [Related]
5. Tetrahydro-beta-carbolines: affinities for tryptamine and serotonergic binding sites.
Cascio CS; Kellar KJ
Neuropharmacology; 1982 Nov; 21(11):1219-21. PubMed ID: 7177348
[TBL] [Abstract][Full Text] [Related]
6. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
[TBL] [Abstract][Full Text] [Related]
7. [3H]tryptamine autoradiography in rat brain and choroid plexus reveals two distinct sites.
Perry DC
J Pharmacol Exp Ther; 1986 Feb; 236(2):548-59. PubMed ID: 3003349
[TBL] [Abstract][Full Text] [Related]
8. [3H]tryptamine binding sites of rat cerebral cortex: pharmacological profile and plasticity.
Graham D; Langer SZ
Neuropharmacology; 1987 Aug; 26(8):1093-7. PubMed ID: 3116448
[TBL] [Abstract][Full Text] [Related]
9. Autoradiographic localization of 3H-paroxetine-labeled serotonin uptake sites in rat brain.
De Souza EB; Kuyatt BL
Synapse; 1987; 1(5):488-96. PubMed ID: 2975068
[TBL] [Abstract][Full Text] [Related]
10. Structural relationships in the inhibition of [3H]tryptamine binding to rat brain membranes in vitro by phenylalkylamines.
Martin LL; Roland DM; Neale RF; Wood PL
Eur J Pharmacol; 1986 Dec; 132(1):53-5. PubMed ID: 3816964
[TBL] [Abstract][Full Text] [Related]
11. Autoradiographic localization and pharmacology of unique [3H]tryptamine binding sites in rat brain.
Altar CA; Wasley AM; Martin LL
Neuroscience; 1986; 17(1):263-73. PubMed ID: 3960312
[TBL] [Abstract][Full Text] [Related]
12. Characterization of [3H]tryptamine binding sites in brain.
Cascio CS; Kellar KJ
Eur J Pharmacol; 1983 Nov; 95(1-2):31-9. PubMed ID: 6667714
[TBL] [Abstract][Full Text] [Related]
13. [3H]tetrahydrotrazodone binding. Association with serotonin binding sites.
Kendall DA; Taylor DP; Enna SJ
Mol Pharmacol; 1983 May; 23(3):594-9. PubMed ID: 6865906
[TBL] [Abstract][Full Text] [Related]
14. Multiple 3H-5-hydroxytryptamine binding sites in rat brain.
Nelson DL; Pedigo NW; Yamamura HI
J Physiol (Paris); 1981; 77(2-3):369-72. PubMed ID: 7288652
[TBL] [Abstract][Full Text] [Related]
15. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.
D'Amato RJ; Largent BL; Snowman AM; Snyder SH
J Pharmacol Exp Ther; 1987 Jul; 242(1):364-71. PubMed ID: 3475452
[TBL] [Abstract][Full Text] [Related]
16. Characterization and quantitative autoradiography of [3H]tryptamine binding sites in rat brain.
Kaulen P; Brüning G; Rommelspacher H; Baumgarten HG
Brain Res; 1986 Feb; 366(1-2):72-88. PubMed ID: 3697697
[TBL] [Abstract][Full Text] [Related]
17. The distribution of serotonin binding sites: a comparison of 3H-serotonin binding in membrane preparations of rat gut and rat brain.
Heltzel JA; Vogel WH
Adv Biochem Psychopharmacol; 1983; 37():385-94. PubMed ID: 6637601
[No Abstract] [Full Text] [Related]
18. [3H]dihydroergotamine as a high-affinity, slowly dissociating radioligand for 5-HT1B binding sites in rat brain membranes: evidence for guanine nucleotide regulation of agonist affinity states.
Hamblin MW; Ariani K; Adriaenssens PI; Ciaranello RD
J Pharmacol Exp Ther; 1987 Dec; 243(3):989-1001. PubMed ID: 2826763
[TBL] [Abstract][Full Text] [Related]
19. Tremorigenic effect and inhibition of tryptamine and serotonin receptor binding by beta-carbolines.
Airaksinen MM; Lecklin A; Saano V; Tuomisto L; Gynther J
Pharmacol Toxicol; 1987 Jan; 60(1):5-8. PubMed ID: 3562389
[TBL] [Abstract][Full Text] [Related]
20. [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.
Leysen JE; Niemegeers CJ; Van Nueten JM; Laduron PM
Mol Pharmacol; 1982 Mar; 21(2):301-14. PubMed ID: 7099138
[No Abstract] [Full Text] [Related]
[Next] [New Search]
